A Clinical trial to study the effects of Histaminum Hydrochloricum and Individualised Homoeopathic remedy in Allergic Rhinitis

Efficacy of Histaminum hydrochoricum 30 versus Individualised Homoeopathic medicine in reducing symptoms of Allergic Rhinitis : A Double Blind Randamised Controlled Trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060158

Enrollment

Registered

2023-11-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Homoeopathic Medicine Histaminum hydrochloricum 30 in reducing of symptoms of Allergic Rhinitis: Each participant will be randomly allocated to 2 groups. Group A will be given Histaminu

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed cases of allergic rhinitis 2. Both sexes of age 18-60 years 3. Patients with serum IgE level above 150 IU/ml or Absolute Eosinophil Count level above 440 cells/microlitre.

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic illnesses like Hypertension, Diabetes Mellitus. 2. Patients complicated with sinusitis,otitis media 3. Patients on other medication for allergic rhinitis 4. Patients with bronchial asthma 5. Pregnant ladies and lactating mothers

Design outcomes

Primary

Measure	Time frame
Change in TNSS scoreTimepoint: once in a month for 1 year	—

Secondary

Measure	Time frame
Reduction in IgE and AEC values.Timepoint: once in 3 months for 1 year	—

Countries

India

Contacts

Public ContactDr RS Krishneswari

National Homoeopathy Research Instituite in Mental Health, Kottayam

krishneswarirs@gmail.com9445646864

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026